Professor Vaibhav Modgil

That's not right.

But the group in which people get twitched in terms of giving them testosterone

are the ones that have been treated, definitively treated.

So they're radical.

They're a radical prostatectomy group, you know, and that's completely understandable.

And I've got colleagues that, you know, still go to our annual meeting and other conferences around the world.

People say, oh, I'm not taking that risk, not on my watch, you know, because I just don't know how that's going to turn out for the patient.

And heaven forbid they'll get a recurrence of their prostate cancer.

so that they can't get breast cancer but it's not the same thing no it no it well it is and it isn't i mean i'm not a i'm not a cancer pathologist or a cancer specialist um but the entire idea of surveying people in terms of doing blood tests scans etc also hinges very closely on the on the kind of disease they had in the first place not all prostate cancers are the same

So if you've got a localized prostate cancer and it's been definitively treated, the surgical margins are negative.

And depending on the initial grade of your prostate cancer, your likelihood of recurrence might be drastically different to an individual who, for example, had a high grade prostate cancer.

But nonetheless, they all require surveillance.

Absolutely not.

It's really nuanced.

Yeah.

I've got patients who've had prostate cancer and I've given them testosterone therapy.

But again, it's all about the conversation that you have.

You know, medicine is...

at least 50% counselling your patient.

Gone are the days where you say to the patient, you're not doing that, you are doing this.